• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

Brainstorm Health: Digital Mental Health Therapy, State of Obamacare, Johnson & Johnson Verdict

By
Sy Mukherjee
Sy Mukherjee
and
Clifton Leaf
Clifton Leaf
By
Sy Mukherjee
Sy Mukherjee
and
Clifton Leaf
Clifton Leaf
October 18, 2017, 2:36 PM ET

Hey there, readers! This is Sy.

Woebot Labs is on a mission to make mental health talk therapy accessible online. Its platform offers an AI-fueled chatbot—available via Facebook Messenger—as a digital therapist that’s available around the clock. Designed by Stanford University experts, Woebot can chat with users about how they’re feeling and present strategies for coping with stress and depression. And now, it has the support of Andrew Ng, a machine learning and AI pioneer who is now joining Woebot’s board of directors as its chairman.

“If you look at the societal need, as well as the ability of AI to help, I think that digital mental-health care checks all the boxes,” Ng tells MIT Technology Review. “If we can take a little bit of the insight and empathy [of a real therapist] and deliver that, at scale, in a chatbot, we could help millions of people.”

Ng was previously the chief scientist at Baidu and helped found Google’s Brain initiative.

Read on for the day’s news.

Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

DIGITAL HEALTH

CVS Health, Epic team up on drug price transparency project. Electronic medical records giant Epic is teaming up with CVS Health in an effort to lower prescription drug spending by sharing more data about which treatments may be more appropriate and cost-effective for patients. "Working in collaboration with CVS Health allows for enhanced and efficient data integration and decision support for clinicians while relieving administrative burden," said Dr. Gregory Rosencrance, chairman of Cleveland Clinic Medicine Institute, in a statement.

INDICATIONS

Johnson & Johnson wins reversal of $72 million talc powder cancer suit verdict. Drug giant Johnson & Johnson has been grappling with a series of brutal jury verdicts centered on alleged links between its talc powder products (often used for feminine hygiene) and ovarian cancer. But the company got a reprieve Tuesday when one $72 million verdict was reversed by a federal appeals court.(Fortune)

THE BIG PICTURE

What in the world is going on with Obamacare? Are you confused about what is happening with the Affordable Care Act? Don't worry, so is everyone. Following the Trump administration's series of actions aimed at dismantling Obamacare provisions last week, two Senators announced a bipartisan deal on legislation to shore up the health law's marketplaces on Tuesday. But while President Donald Trump initially appeared sympathetic to the proposed compromise, he has since indicated he cannot support it because he considers it a "bailout" for insurance companies. House Speaker Paul Ryan isn't particularly enthusiastic about it, either.

REQUIRED READING

Elon Musk's Tesla Powerwalls Have Landed in Puerto Rico, by John Patrick Pullen

Ride-Hailing Isn't Even Close to Being a Big Industry Yet, by Andrew Nusca

Why At Least One AI Expert Isn't Concerned About AI Taking Over the World, by Adam Lashinsky

Ethereum Founder: Central Banks Far from Digital Currency, by Jeff John Roberts

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

Find past coverage. Sign up for other Fortunenewsletters.
About the Authors
By Sy Mukherjee
See full bioRight Arrow Button Icon
By Clifton Leaf
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.